As­traZeneca’s Pas­cal So­ri­ot says new rise in pay is ‘re­al­ly about’ po­ten­tial suc­ces­sor

As­traZeneca CEO Pas­cal So­ri­ot vig­or­ous­ly de­fend­ed his re­cent­ly se­cured $23.5 mil­lion pay pack­age, cit­ing the UK phar­ma’s need to com­pete for tal­ent.

“It re­al­ly is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER